Prices are updated after-hours

Nasdaq 2021 - 01 - 29

Horizon Bancorp, Inc.

HBNC | $11.85 3.77% 3.63% 230K

(0.0% 1d) (-6.5% 1m) (11.9% 1y) (0.0% 2d) (4.9% 3d) (3.8% 7d) (85.96% volume)
Earnings Calendar: 2024-01-24
Market Cap: $ 522,717,412
http://www.horizonbank.com
Sec Filling | Patents | 839 employees

(US) Horizon Bancorp, Inc. is a bank holding company, which through its subsidiary, engages in the provision of commercial and retail banking services. It offers personal banking, business banking, investment and trust, and mortgage services. The company was founded in 1873 and is headquartered in Michigan City, IN.

add to watch list Paper trade email alert is off

Horizon Therapeutics Public Limited Company

HZNP | $116.3 0.03% 29M

Health Technology

(0.0% 1d) (0.0% 1m) (4.5% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (383.01% volume)
Earnings Calendar: 2023-11-01
Market Cap: $ 26,632,068,258
http://www.horizontherapeutics.com
Sec Filling | Patents | 1200 employees

Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.

add to watch list Paper trade email alert is off

Hostess Brands, Inc.

TWNK | $33.3 0.07% 53M

Consumer Non-Durables

(0.0% 1d) (0.0% 1m) (34.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1410.03% volume)
Earnings Calendar: 2023-11-01
Market Cap: $ 4,426,475,261
http://www.hostessbrands.com
Sec Filling | Patents | 2000 employees

Hostess Brands, Inc. engages in developing, manufacturing, marketing, selling and distributing baked goods. It operates through following segments: Sweet Baked Goods and In-Store Bakery. The Sweet Baked Goods segment consists of fresh and frozen baked goods and bread products that are sold under the Hostess, Dolly Madison, Cloverhill and Big Texas brands. The In-Store Bakery segment consists of Superior on Main branded and store-branded products sold through the in-store bakery section of grocery and club stores. The company was founded in 1919 and is headquartered in Kansas, MO.

brands

add to watch list Paper trade email alert is off

Hoth Therapeutics, Inc.

HOTH | $1.22 3.39% 3.28% 22K

Health Technology

(0.0% 1d) (-27.3% 1m) (-40.0% 1y) (1.7% 2d) (-2.4% 3d) (0.0% 7d) (13.16% volume)
Earnings Calendar:
Market Cap: $ 5,964,341
http://www.hoththerapeutics.com
Sec Filling | Patents | 3 employees

Hoth Therapeutics, Inc. is a development stage biopharmaceutical company, which engages in the provision and development of therapeutic platform. The company focuses on the patients suffering from conditions such as atopic dermatitis, also known as eczema. It offers BioLexa Platform, a proprietary, patented, drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern in May 2017 and is headquartered in New York, NY.

dermatitis atopic dermatitis treatment

add to watch list Paper trade email alert is off

Hudson Global, Inc.

HSON | $16.62 -1.66% -1.68% 240

Commercial Services

(0.0% 1d) (-4.5% 1m) (-19.8% 1y) (0.0% 2d) (0.0% 3d) (-2.7% 7d) (264.27% volume)
Earnings Calendar: 2024-03-28
Market Cap: $ 46,791,283
http://www.hudson.com
Sec Filling | Patents | 390 employees

(US) Hudson Global, Inc. is a talent solutions company, which provides specialized professional-level recruitment and related talent solutions worldwide. The firm operates through its segments: Hudson Americas, Hudson Asia Pacific, and Hudson Europe. Its services include permanent recruitment, contracting, recruitment process outsourcing and talent management solutions. The company was founded in 1987 and is headquartered in New York, NY.

add to watch list Paper trade email alert is off

Humanigen, Inc.

HGEN | $0.0361 -61.5% 120M

Health Technology

(0.0% 1d) (0.0% 1m) (-77.7% 1y) (0.0% 2d) (0.0% 3d) (-81.1% 7d) (23283.32% volume)
Earnings Calendar: 2022-11-09
Market Cap: $ 4,298,793
http://www.humanigen.com
Sec Filling | Patents | 2 employees

(US) Humanigen, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of cell and gene therapies for the treatment of cancers through novel human granulocyte-macrophage colony-stimulating factor neutralization and gene-knockout platforms. The company was founded by Jeng-Horng Her & Robert F. Balint on March 15, 2000 and is headquartered in Burlingame, CA.

cancer gene therapies t-cell treatment ceiling

add to watch list Paper trade email alert is off

Hurco Companies, Inc.

HURC | $19.02 -1.5% -1.52% 25K

Producer Manufacturing

(0.0% 1d) (-8.2% 1m) (-16.5% 1y) (0.0% 2d) (-1.4% 3d) (-1.7% 7d) (5.64% volume)
Earnings Calendar:
Market Cap: $ 123,744,748
http://www.hurco.com
Sec Filling | Patents | 785 employees

(US) Hurco Cos., Inc. is an international industrial technology company, which engages in the designing, manufacturing and selling of computerized machine tools. It also offers machine tool components, software options, control upgrades, accessories and replacement parts for its products, as well as customer service and training and applications support. The company was founded by Edward Humston and Gerald V. Roch in 1968 and is headquartered in Indianapolis, IN.

add to watch list Paper trade email alert is off

Huron Consulting Group Inc.

HURN 4 | $92.425 2.2% 2.15% 120K

Commercial Services

(0.0% 1d) (-3.2% 1m) (10.8% 1y) (0.0% 2d) (1.2% 3d) (1.3% 7d) (4.28% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 1,707,496,143
http://www.huronconsultinggroup.com
Sec Filling | Patents | 3750 employees

Huron Consulting Group, Inc. engages in the provision of operational and financial consulting services. It operates through the following business segments: Healthcare, Business Advisory, and Education. The Healthcare segment provides advisory services in the areas of care transformation, financial and operational excellence, technology and analytics, and leadership development to national and regional hospitals and integrated health systems, academic medical centers, community hospitals, and medical groups. The Business Advisory segment offers services to large and middle market organizations, not-for-profit organizations, lending institutions, law firms, investment banks, and private equity firms. The Education segment includes consulting and technology solutions to higher education institutions and academic medical centers. The company was founded in March 2002 and is headquartered in Chicago, IL.

education urea profitable

add to watch list Paper trade email alert is off

IAC/InterActiveCorp

IAC | $48.0 0.86% 0.85% 390K

Technology Services

(0.0% 1d) (-8.9% 1m) (-4.0% 1y) (0.0% 2d) (2.0% 3d) (0.2% 7d) (1.17% volume)
Earnings Calendar: 2024-02-13
Market Cap: $ 3,842,967,456
http://www.iac.com
Sec Filling | Patents | n/a employees

IAC Holdings, Inc. engages in media and Internet business. It operates through the following segments: ANGI Homeservices, Vimeo, Dotdash, Applications, Ask Media Group, and Emerging and Other. The ANGI Homeservices segment offers repairing, remodeling, cleaning, and landscaping through category-transforming products under HomeAdvisor, Angie's List, Handy, and Fixd Repair brands. The Vimeo segment operates a global video platform for creative professionals, small and medium businesses, organizations, and enterprises to connect with their audiences, customers, and employees. The Dotdash segment includes a portfolio of digital brands that provide information and inspiration in select vertical content categories. The Applications segment consists of direct-to-consumer downloadable desktop applications and the business-to-business partnership operations as well as global subscription mobile applications through Apalon, iTranslate, and TelTech. The Ask Media Group segment is a collection of websites that provide general search services and information. The Emerging and Other segment comprises of platforms Care.com, Bluecrew, and NurseFly. The company was founded on November 19, 2019 and is headquartered in New York, NY.

brands

add to watch list Paper trade email alert is off

ICF International, Inc.

ICFI | $140.185 1.52% 1.49% 47K

Commercial Services

(0.0% 1d) (-6.6% 1m) (28.3% 1y) (0.0% 2d) (0.1% 3d) (0.0% 7d) (-1.83% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 2,623,614,985
http://www.icfi.com
Sec Filling | Patents | 7000 employees

(US) ICF International, Inc. engages in the provision of technology-based solutions and services to government and commercial clients. It serves the Energy, Environment, and Infrastructure; Health, Education, and Social Programs; Safety and Security; and Consumer and Financial markets. The company was founded in 1969 and is headquartered in Fairfax, VA.

energy education security

add to watch list Paper trade email alert is off

ICU Medical, Inc.

ICUI | $95.795 -1.14% -1.15% 180K

Health Technology

(0.0% 1d) (-2.8% 1m) (-47.1% 1y) (0.0% 2d) (-0.1% 3d) (-1.4% 7d) (29.72% volume)
Earnings Calendar: 2024-02-27
Market Cap: $ 2,334,053,030
http://www.icumed.com
Sec Filling | Patents | 8000 employees

(United States) ICU Medical, Inc. engages in the development, manufacture, and sale of innovative medical devices used in vascular therapy and critical care applications. Its product portfolio includes intravenous smart pumps, sets, connectors, closed transfer devices for hazardous drugs, cardiac monitoring systems, IV solutions, IV smart pumps with pain management and safety software technology, dedicated and non-dedicated IV sets and needle-free connectors. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

Drugs

Acetic Acid (Acetic Acid)
Aminosyn II (ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, HISTIDINE, PROLINE, SERINE, N-ACETYLTYROSINE, and GLYCINE)
Aminosyn-PF (ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, PROLINE, SERINE, TAURINE, and TYROSINE)
Dextrose (dextrose)
Dextrose (dextrose monohydrate)
Dextrose and Sodium Chloride (DEXTROSE MONOHYDRATE and SODIUM CHLORIDE)
Glycine (GLYCINE)
Ionosol MB and Dextrose (DEXTROSE MONOHYDRATE, SODIUM LACTATE, POTASSIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM PHOSPHATE, MONOBASIC, and SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE)
Lactated Ringers (SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, and CALCIUM CHLORIDE)
Lactated Ringers and Dextrose (SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE, and DEXTROSE MONOHYDRATE)
Mannitol (MANNITOL)
NORMOSOL-M AND DEXTROSE (dextrose monohydrate, sodium chloride, potassium acetate, and magnesium acetate)
Normosol-R (SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE)
Normosol-R and Dextrose (Dextrose, Sodium Chloride, Sodium Acetate Anhydrous, Sodium Gluconate, Potassium Chloride, and Magnesium Chloride)
Physiosol (SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, and MAGNESIUM CHLORIDE)
Potassium Chloride (POTASSIUM CHLORIDE)
Potassium Chloride in Dextrose (dextrose monohydrate and potassium chloride injection, solution)
Potassium Chloride in Dextrose and Sodium Chloride (DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, and POTASSIUM CHLORIDE)
Potassium Chloride in Lactated Ringers and Dextrose (POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, SODIUM LACTATE, and DEXTROSE MONOHYDRATE)
Potassium Chloride in Sodium Chloride (SODIUM CHLORIDE and POTASSIUM CHLORIDE)
Ringers (SODIUM CHLORIDE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE)
Sodium Chloride (SODIUM CHLORIDE)
Sorbitol-Mannitol (SORBITOL and MANNITOL)
Sterile Water (water)
Sterile Water (WATER)

add to watch list Paper trade email alert is off

IDEXX Laboratories, Inc.

IDXX | $476.29 -0.31% -0.31% 570K

Health Technology

(0.0% 1d) (-10.5% 1m) (-3.9% 1y) (0.0% 2d) (-0.4% 3d) (-3.0% 7d) (6.63% volume)
Earnings Calendar: 2024-02-05
Market Cap: $ 39,557,846,339
http://www.idexx.com
Sec Filling | Patents | 9200 employees

IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: CAG, Water, LPD, and Other. The CAG segment develops, designs, manufactures, and distributes products and performs services for veterinarians and the biomedical analytics market, primarily related to diagnostics and information management. The Water segment develops, designs, manufactures, and distributes a range of products used in the detection of various microbiological parameters in water. The LPD segment develops, designs, manufactures, and distributes diagnostic tests and related instrumentation and performs services, which are used to manage the health status of livestock and poultry, to improve producer, and to ensure the quality and safety of milk and food. The Other operating segment combines and presents products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983 and is headquartered in Westbrook, ME.

insurance animals veterinarians food diagnostics veterinary

add to watch list Paper trade email alert is off

IF Bancorp, Inc.

IROQ 4 | $16.25 0.72% 93

Finance

(0.0% 1d) (-1.1% 1m) (5.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (13.86% volume)
Earnings Calendar:
Market Cap: $ 54,512,673
http://www.iroquoisfed.com
Sec Filling | Patents | 110 employees

IF Bancorp, Inc. is a holding company, which engages in directing, planning, and coordinating the business activities of Iroquois Federal Savings. The firm through its subsidiary, offers variety of deposits accounts, including savings accounts, certificate of deposit, money market accounts, commercial and personal checking accounts, individual retirement accounts, and health savings accounts. The company was founded in March 2011 and is headquartered in Watseka, IL.

add to watch list Paper trade email alert is off

IGM Biosciences, Inc.

IGMS | $7.2 -2.83% -2.92% 220K

Health Technology

(0.0% 1d) (-29.6% 1m) (-36.3% 1y) (-2.8% 2d) (-11.4% 3d) (-23.5% 7d) (-50.91% volume)
Earnings Calendar: 2023-11-02
Market Cap: $ 239,660,676
http://www.igmbio.com
Sec Filling | Patents | 64 employees

(United States) IGM Biosciences, Inc. operates as a biotechnology company which develops antibodies for the treatment of cancer. It offers IgM platform to expand upon the inherent properties of IgM antibodies and to allow for the rapid development of engineered therapeutic antibodies. The firms product pipe line includes IGM-2323, which is a CD20 x CD3 bispecific IgM antibody designed to treat patients with B cell Non-Hodgkin's lymphoma and other B cell malignancies; IGM-8444, which is an IgM antibody targeting Death Receptor 5 for the treatment of patients with solid and hematologic malignancies; and IGM-7354, which will target the delivery of IL-15 with the goal of inducing immune cell stimulation and proliferation. The company was founded in 2010 and is headquartered in Mountain View, CA.

cancer antibody t-cell cd73 msa treatment ceiling

add to watch list Paper trade email alert is off

II-VI Incorporated

IIVI S | $227.08 5.49% 0.0% 0

Electronic Technology

(0.0% 1d) (0.0% 1m) (38.1% 1y) (0.0% 2d) (1.9% 3d) (0.0% 7d) (946.44% volume)
Earnings Calendar: 2022-11-08
Market Cap: $ 7,105,479,212
http://www.ii-vi.com
Sec Filling | Patents | 22969 employees

II-VI, Inc. engages in the development, refinement, manufacturing, and marketing of engineered materials and opto-electronic components and devices for precision in the field of industrial materials processing, optical communications, aerospace and defense, consumer electronics, semiconductor capital equipment, life sciences, and automotive applications and markets. It operates through the following segments: Photonic Solutions and Compound Semiconductors. The Photonic Solutions segment manufactures crystal materials, optics, microchip lasers and optoelectronic modules for use in optical communication networks and other diverse consumer and commercial applications, pump lasers, optical isolators, and optical amplifiers and micro-optics for optical amplifiers, for both terrestrial and submarine applications within the optical communications market. The Compound Semiconductors segment designs, manufactures and markets optical and electro-optical components and materials, infrared optical components and high-precision optical assemblies for aerospace and defense, medical and commercial laser imaging applications, semiconductor lasers and detectors for optical interconnects and sensing applications, unique engineered materials for thermoelectric and silicon carbide applications servicing the semiconductor, aerospace and defense and medical markets. The company was founded Carl J. Johnson in 1971 and is headquartered in Saxonburg, PA.

defense electronics optical optoelectronic automotive semiconductor photo communication

add to watch list Paper trade email alert is off

Illumina, Inc.

ILMN | $117.43 0.63% 0.63% 1.4M

Health Technology

(0.0% 1d) (-14.6% 1m) (-48.4% 1y) (0.0% 2d) (-0.7% 3d) (-8.1% 7d) (-24.01% volume)
Earnings Calendar: 2024-02-08
Market Cap: $ 18,701,359,861
http://www.illumina.com
Sec Filling | Patents | 7700 employees

(US) Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The firm's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

genomic genetic

add to watch list Paper trade email alert is off

ImmunoGen, Inc.

IMGN | $31.23 0.03% 49M

Health Technology

(0.0% 1d) (0.0% 1m) (633.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 8,315,433,277
http://www.immunogen.com
Sec Filling | Patents | 75 employees

(US) ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded in March 1981 and is headquartered in Waltham, MA.

cancer antibody

add to watch list Paper trade email alert is off

Impinj, Inc.

PI | $116.23 -4.79% -5.03% 340K

Electronic Technology

(0.0% 1d) (-7.7% 1m) (-16.9% 1y) (0.0% 2d) (-3.1% 3d) (-1.8% 7d) (4.09% volume)
Earnings Calendar: 2024-02-08
Market Cap: $ 3,214,741,062
http://www.impinj.com
Sec Filling | Patents | 272 employees

(US) IImpinj, Inc. engages in the development and sale of RAIN, a radio frequency identification solution. Its platform allows inventory management, patient safety, asset tracking and item authentication for the retail, healthcare, supply chain and logistics, hospitality, food and beverage, and industrial manufacturing industries. The company was founded by Carver Mead and Chris Diorio in April 2000 and is headquartered in Seattle, WA.

food

add to watch list Paper trade email alert is off

Inari Medical, Inc.

NARI S | $38.58 -0.16% -0.16% 790K

Health Technology

(0.0% 1d) (-14.7% 1m) (-43.8% 1y) (0.0% 2d) (-0.3% 3d) (-2.3% 7d) (22.11% volume)
Earnings Calendar: 2024-02-28
Market Cap: $ 2,236,118,212
http://www.inarimedical.com
Sec Filling | Patents | 199 employees

Inari Medical, Inc. operates as a medical device company. It develops, manufactures, markets and sells devices for the interventional treatment of venous diseases. Its products include FlowTriever system and ClotTriever system. The company was founded by Brian J. Cox, Paul Lubock and Robert F. Rosenbluth in June 2011 and is headquartered in Irvine, CA.

msa treatment

add to watch list Paper trade email alert is off

Incyte Corporation

INCY | $52.3 -0.98% -0.99% 2.2M

Health Technology

(0.0% 1d) (-9.3% 1m) (-29.8% 1y) (-0.9% 2d) (-0.7% 3d) (-2.0% 7d) (19.17% volume)
Earnings Calendar: 2024-02-13
Market Cap: $ 11,742,716,494
http://www.incyte.com
Sec Filling | Patents | 1456 employees

(US) Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib). The company was founded by Roy A. Whitfield in April 1991 and is headquartered in Wilmington, DE.